Clinical trial
Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.
NCT00878826 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.
- Lead sponsor
- Stanford University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- October 31, 2014
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.